skip to Main Content

Enhance your offering with our heart health assessments

Choose the integration possibility that fits best with your business

1 in 3

adults develop arrhythmias throughout their life, often without warning signs1

5X

more risk of stroke when diagnosed with atrial fibrillation1

20%

direct cost savings when implemented in routine care2

89%

of users feel instant peace of mind without the need for a GP appointment3

FibriCheck, your heart health partner

FibriCheck is a CE-certified, FDA/TGA-approved medical application powered by AI. It can be used to detect and monitor arrhythmias, including atrial fibrillation, and to objectify symptoms throughout the entire patient lifecycle, without the need for additional hardware.

Seamless integration

We offer a range of integration options tailored to your needs

No additional hardware

To perform measurements, users only need a smartphone

No regulatory hassle

Make use of our existing regulatory approvals and avoid regulatory delays

Reliable

Clinically validated in over 50 studies, CE-certified and FDA-approved

Choose the integration option that fits your business needs

Use the FibriCheck app as is

Stand-alone

With just a link or a QR code, you can offer the FibriCheck app as is.

App-to-app

Create a deep link between your mobile application and the FibriCheck application.

Integrate the FibriCheck functionalities

SDK integration

Integrate heart rhythm measurements in your own mobile application, powered by FibriCheck technology.

API integration

Get access to FibriCheck data in your application.

The possibilities of FibriCheck

FibriCheck partners with Pfizer and AlTibbi for the first of its kind atrial fibrillation awareness campaign in the UAE

FibriCheck is thrilled to announce its strategic partnership with Pfizer and AlTibbi, the leading digital health platform in the MENA region…

Belgian health insurer Helan offers FibriCheck for free to its clients

Since the beginning of 2022, several Belgian health insurers – including Helan – have started with a reimbursement of up…

FibriCheck partners with Pfizer and AlTibbi for the first of its kind atrial fibrillation awareness campaign in the UAE

FibriCheck is thrilled to announce its strategic partnership with Pfizer and AlTibbi, the leading digital health platform in the MENA region…

Belgian health insurer Helan offers FibriCheck for free to its clients

Since the beginning of 2022, several Belgian health insurers – including Helan – have started with a reimbursement of up…

Success stories

Get in touch

References
1. ESC, 2020, Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)
2. Dr. Betz, K. (2023, April 18). Changes in healthcare utilisation and declarable care products during the implementation of a remote atrial fibrillation management pathway: The TeleCheck-AF project [e-cardiology award session]. EHRA 2023, Barcelona
3. Unpublished internal document

Back To Top
Search